Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Videos

Early-Stage Non-Small Cell Lung Cancer With a PD-L1 of 80%

Corey Langer, MD

 

Corey Langer, MD, Abramson Cancer Center, Philadelphia, Pennsylvania, discusses the course of treatment he would take for a patient with early-stage non-small cell lung cancer (NSCLC) with a PD-L1 of 80%. 

© 2024 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Oncology Learning Network or HMP Global, their employees, and affiliates. 

Advertisement

Advertisement

Advertisement

Advertisement